Centre Publications


  1. van Schalkwyk E, Iyaloo S, Naicker SD, Maphanga TG, Mpembe RS, Zulu TG, Mhlanga M, Mahlangu S, Maloba B, Ntlemo G, Sanyane K, Mawela D and Govender NP for GERMS-SA. Large outbreaks of fungal and bacterial bloodstream infection in a South African neonatal unit. Emerg Infect Dis 2018. In press
  2. Cassim N, Coetzee L, Govender NP, Glencross DK. District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal province, South Africa. Afr J Lab Med 2018. In press
  3. Wake R, Jarvis JN, Harrison TS, Govender NP. Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay. J Acquir Imm Defic Syndr 2018. In press
  4. Govender NP and Glencross DK. National coverage of reflex cryptococcal antigen screening: a milestone achievement in the care of persons with advanced HIV disease. S Afr Med J 2018. In press
  5. Singh-Moodley A, et al. Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa. J Infect Dev Countries 2018. In press
  6. Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G, Kruger J, Govender NP, Boulle A. The continuing burden of advanced HIV disease over ten years of increasing antiretroviral therapy coverage in South Africa. Clin Infect Dis 2018. Mar 4;66(suppl_2):S118-S125.
  7. Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, Penazzato M, Vojnov L, Doherty M; Guideline Development Group for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. Managing Advanced HIV Disease in a Public Health Approach. Clin Infect Dis. 2018 Mar 4;66(suppl_2):S106-SS110.
  8. Schwartz IS, Lerm B, Hoving JC, Kenyon C, Horsnell WG, Basson WJ, Otieno-Odhiambo P, Govender NP, Colebunders R, Botha A. Emergomyces africanus in soil, South Africa. Emerg Infect Dis. 2018 Feb;24(2):377-380.
  9. Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, Nel JS, Mashamaite S, Adelekan A, Chiller TM, Jarvis JN, Harrison TS, Govender NP. High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients. Clin Infect Dis 2018 Feb 10;66(5):686-692.
  10. Crombie K, Spengane Z, Locketz M, Dlamini S, Lehloenya R, Wasserman S, Maphanga TG, Govender NP, Kenyon C, Schwartz IS. Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy. PLoS Negl Trop Dis 2018 Mar 8;12(3):e0006173.



  1. Cole DC, Govender NP, Chakrabarti A, Sacarlal J, Denning DW. Improving fungal disease identification and management – combined health systems and public health approaches are needed. Lancet Infect Dis 2017. Jul 31. pii: S1473-3099(17)30308-0.
  2. Rajasingham R, Smith R, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect Dis. 2017. Aug;17(8):873-881.
  3. Chen Y, Farrer RA, Giamberardino C, Sakthikumar S, Jones A, Yang T, Tenor JL, Wagih O, Van Wyk M, Govender NP, Mitchell TG, Litvintseva AP, Cuomo CA, Perfect JR. Microevolution of Serial Clinical Isolates of Cryptococcus neoformans grubii and C. gattii. MBio. 2017 Mar 7;8(2). pii: e00166-17.
  4. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous emergence of multidrug resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134-140.
  5. Cronjé N, Schwartz IS, Retief L, Bastos ADS, Matthee S, Preiser W, Bennett NC, Maphanga T, Govender NP, Colebunders R, Kenyon C. Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa. Med Mycol 2017. https://doi.org/10.1093/mmy/myx065
  6. Schwartz IS, Kenyon C, Lehloenya R, Claasens S, Spengane Z, Prozesky H, Burton R, Parker A, Wasserman S, Meintjes G, Mendelson M, Taljaard J, Schneider JW, Beylis N, Maloba B, Govender NP, Colebunders R, Dlamini S. AIDS-related endemic mycoses in Western Cape, South Africa and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions. Open Forum Infect Dis 2017. 2017 Aug 25;4(4):ofx186.
  7. Lerm B, Kenyon C Schwartz I, Kroukamp H, de Witt R, Govender N, de Hoog S, Botha A. First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope Cryptococcus neoformans. FEMS Yeast Research 2017. 2017 Nov 1;17(7).
  8. Perovic O, Singh-Moodley A, Govender NP, Kularatne R, Whitelaw A, Chibabhai V, Naicker P, Mbelle N, Lekalakala R, Quan V, Samuel C, van Schalkwyk E for GERMS-SA. Small proportion of community-associated methicillin-resistant Staphylococcus aureus bacteraemia, as compared to healthcare-associated cases, in two South African provinces. Eur J Clin Microbiol Infect Dis 2017. 36(12):2519-2532.
  9. Espinel-Ingroff A, Abreu D, Almeida-Paes R, Brilhante R, Chakrabarti A, Chowdhary A, Hagen F, Córdoba S, González G, Govender N, Guarro J, Johnson E, Kidd S, Pereira S, Rodrigues A, Rozental S, M Szeszs, Raquel Ballesté Alaniz, Alexandro Bonifaz, L. Bonfietti, Luana Borba-Santos, Javier Capilla, A Colombo, Maribel Dolande, M Isla, Marcia Melhem, A Mesa-Arango, Manoel M. Evangelista de Oliveira, Maria Panizo, Zoilo Pires de Camargo, Rosely Zancope-Oliveira, Jacques Meis, and John Turnidge. Multicenter and international study of MIC/MEC distributions for definition of epidemiological cutoff values (ECVs) for species of Sporothrix identified by molecular methods. Antimicrob Agent Chemother 2017. 61(10). pii: e01057-17
  10. Molloy SF, Chiller T, Greene G, Govender NP, Kanyama C, Mfinanga S, Boulware D, Bury J, Dromer F, Denning D, Day J, Mapoure YN, Stone N, Bicanic T, Jarvis J, Lortholary O, Harrison T, Jaffar S, Loyse A. Cryptococcal meningitis: a neglected NTD? PLoS Negl Trop Dis. 2017. Jun 29;11(6):e0005575.
  11. Maphanga TG, Britz E, Zulu TG, Mpembe RS, Naicker SD, Schwartz IS, Govender NP. In vitro antifungal susceptibility of the yeast- and mould-phases of the dimorphic fungal pathogen, Emergomyces africanus (formerly Emmonsia species), from HIV-infected South African patients. J Clin Microbiol. 2017 Jun;55(6):1812-1820.
  12. Dukik K, Muñoz JF, Jiang Y, Feng P, Sigler L, Stielow JB, Freeke J, Jamalian A, van den Ende BG, McEwen JG, Clay OK, Schwartz ISS, Govender NP, Maphanga TG, Cuomo CA, Moreno L, Kenyon C, Borman AM, de Hoog S. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017 May;60(5):296-309.
  13. Magobo RE, Naicker SD, Wadula J, Nchabaleng M, Coovadia Y, Hoosen A, Lockhart SR and Govender NP for the TRAC-South Africa group. Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory-based sentinel surveillance, South Africa, 2009-2010. Mycoses. 2017 May;60(5):320-327.
  14. Greene GS, Sriruttan C, Le T, Chiller T and Govender NP. Looking for Fungi in All the Right Places: Screening for Cryptococcal Disease and Other AIDS-Related Mycoses Before Antiretroviral Treatment Initiation. Curr Opin HIV AIDS. 2017. Mar;12(2):139-147.
  15. Shuping LL, Kuonza L, Musekiwa A, Iyaloo S, Perovic O. Hospital-associated methicillin-resistant Staphylococcus aureus: A cross-sectional analysis of risk factors in South African tertiary public hospitals. PLoS One 2017. Nov 16;12(11):e0188216.
  16. Schellack N, Benjamin D, Brink A, Duse A, Faure K, Goff D, Mendelson M, Meyer J, Miot J, Perovic O, Pople T, Suleman F, van Vuuren M, Essack S. A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa.Int J Infect Dis. 2017 Nov;64:100-106.
  17. Singh-Moodley A, Perovic O, Mtshali S, Ismail A, Allam M. Genome Announc. Draft Genome Sequence of a Multidrug-Resistant Serratia marcescens Strain, Isolated from a Patient with Peritoneal Cancer in South Africa. 2017 Jun 29;5(26). pii: e00580-17.
  18. Mohlabeng R, Shuping L, Perovic O, Singh-Moodley A. The Efficacy of the MicroScan Walkaway System in Reporting Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, South Africa. J Antimicrob Agents 2017, 3:4.



  1. Govender NP, Patel J, Magobo RE, Naicker S, Wadula J, Whitelaw A, Coovadia Y, Kularatne R, Govind C, Lockhart SR, Zietsman IZ on behalf of the TRAC-South Africa group. Emergence of Azole-Resistant Candida parapsilosis causing Bloodstream Infection: Results from Laboratory-Based Sentinel Surveillance, South Africa. J Antimicrob Chemother 2016 Jul;71(7):1994-2004.
  2. Prakash A, Sharma C, Singh A, Singh PK, Kumar A, Hagen F, Govender NP, Colombo AL, Meis JF, Chowdhary A. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization-time of flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect. 2016 Mar;22(3):277.e1-9.
  3. Wake R, Sriruttan C, Glencross DK, Harrison TS, Govender NP. Cryptococcal Antigen Screening in HIV-infected Adults – let’s get straight to the point-of-care. AIDS. 2016 Jan 28;30(3):339-42.
  4. Longley N, Jarvis JN, Meintjes G, Boulle A, Cross A, Kelly N, Govender NP, Bekker LG, Wood R, Harrison TS. Cryptococcal Antigen Screening in Patients Initiating ART In South Africa: A Prospective Cohort Study. Clin Infect Dis. 2016 Mar 1;62(5):581-7.
  5. Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, González G, Govender N, Martín-Mazuelos E, Lackner M, Lass-Flörl C, Linares-Sicilia M, Rodriguez-Iglesias M, Pelaez T, Shields R, Garcia-Effron G, Guinea J, Sanguinetti M, and Turnidge J. A multi-center study of method-dependent epidemiological cutoff values (ECVs) for resistance detection in Candida and Aspergillus spp. to amphotericin B and echinocandins for the Etest agar diffusion method. Antimicrob. Agents Chemother. 2016. Dec 27;61(1). pii: e01792-16.
  6. Britz E, Perovic O, von Mollendorf C, von Gottberg A, Iyaloo S, Quan V, Chetty V, Sriruttan C, Ismail NA, Nanoo A, Musekiwa A, Reddy C, Viljoen K, Cohen C, Govender NP. The epidemiology of meningitis among adults in a South African province with a high HIV prevalence, 2009-2012. PLoS One 2016. Sep 26;11(9):e0163036.
  7. Meiring ST, Fortuin-de Smidt M, Kularatne R, Dawood H, and Govender NP. Prevalence and hospital management of amphotericin B deoxycholate-related toxicities during treatment of HIV-associated cryptococcal meningitis in South Africa. PLoS Negl Trop Dis. 2016 Jul 28;10(7):e0004865.
  8. Larson BA, Rockers PC, Bonawitz R, Sriruttan C, Glencross DK, Cassim N, Coetzee L, Greene GS, Chiller TM, Vallabhaneni S, Long L, van Rensburg C, Govender NP. Screening HIV-infected patients with low CD4 counts for cryptococcal antigenemia prior to initiation of antiretroviral therapy: cost effectiveness of alternative screening strategies in South Africa. PLoS One 2016. Jul 8;11(7):e0158986.
  9. Naicker S, Govender N, Patel J, Zietman IL, Wadula J, Coovadia Y, Kularatne R, Seetharam S and Govender NP. Comparison of species-level identification and antifungal susceptibility results from diagnostic and reference laboratories for bloodstream Candida surveillance isolates, South Africa, 2009-2010. Med Mycol 2016 Nov 1;54(8):816-24.
  10. Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, Cross A, Boulle A, Meintjes G, Govender NP. Evaluation of a Public-sector, Provider-initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e37-42.
  11. Naicker S, Magobo RE, Zulu TG, Maphanga TG, Luthuli N, Lowman W and Govender NP. Two echinocandin-resistant Candida glabrata FKS mutants from South Africa. Med Mycol Case Rep 2016. Mar 21;11:24-6.
  12. Britz E and Govender NP. Global emergence of a multi-drug resistant fungal pathogen, Candida auris. S Afr J Infect Dis 2016; 31(3):69-70.
  13. Wake R and Govender NP. Cryptococcosis in apparently immune-competent patients: taxonomy, epidemiology, pathophysiology and treatment. S Afr J Infect Dis 2016; 31(2):32-34.
  14. Du Plessis D, et al. Laboratory-based surveillance for Pneumocystis pneumonia in South Africa, 2006 through 2010. S Afr J Infect Dis 2016; 1(1):1-6.
  15. van Hougenhouck-Tulleken WG, Mathole G, Karstaedt A, Govind N, Moodley M, Seetharam S, Govender NP, Menezes CN. Disseminated fungal infection in an HIV-infected patient due to Aureobasidium pullulans. S Afr J Infect Dis. 2016; 1(1):1-3.
  16. Perovic O, Schultsz C. Stepwise approach for implementation of antimicrobial resistance surveillance in Africa. Afr J Lab Med. 2016 Oct 31;5(3):482.
  17. Singh-Moodley A, Perovic Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.BMC Infect Dis. 2016 Oct 4;16(1): 536.PMID:27716102
  18. Brink AJ, Van Wyk J, Moodley VM, Corcoran C, Ekermans P, Nutt L, Boyles T, Perovic O, Feldman C, Richards G, Mendelson M.S Afr Med J .The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. 2016 May 10;106(6):30-7.
  19. Mahabeer Y, Singh-Moodley A, Mackanjee H, Perovic O and Mlisana KP. First report of neonatal bacteraemia caused by blaNDM-1 Raoultella ornithinolytica. S Afr J Infect Dis 2016; 1(1):1-3.
  20. Perovic O, Britz E, Chetty V and Singh-Moodley A. Molecular detection of carbapenemase-producing genes in referral Enterobacteriaceae in South Africa: A short report. S Afr Med J 2016;106(10):975-977.




  1. Schwartz IS, Kenyon C, Feng P, Govender NP, Dukik K, Sigler L, Jiang Y, Stielow JB, Muñoz JF, Cuomo CA, Botha A, Stchigel AM, de Hoog S. 50 years of Emmonsia disease in humans: the dramatic emergence of a cluster of novel fungal pathogens. PLoS Pathogens. 2015 Nov 19;11(11):e1005198.
  2. Schwartz IS, Govender NP, Corcoran C, Dlamini S, Prozesky H, Burton R, Mendelson M, Taljaard J, Lehloenya R, Calligaro G, Colebunders R, Kenyon C. Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series. Clin Infect Dis. 2015 Sep 15;61(6):1004-12.
  3. Govender NP, Maphanga TG, Zulu TG, Patel J, Walaza S, Jacobs C, Ebonwu JI , Ntuli S, Naicker SD, Thomas J. An Outbreak of Lymphocutaneous Sporotrichosis among Mine-Workers in South Africa. PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004096.
  4. Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, S. C-A. Chen, G. Eschenauer, D. L. Getsinger, G. M. Gonzalez, Govender NP, A. Grancini, K. E. Hanson, S. E. Kidd, K. Klinker, C. J. Kubin, J.V. Kus, S. R. Lockhart, J. Meletiadis, A. J. Morris, T. Pelaez, G. Quindós, M. Rodriguez-Iglesias, F. Sánchez-Reus, S. Shoham, N. L. Wengenack, N. Borrell Solé, J. Echeverria, J. Esperalba, E. Gómez-G. de la Pedrosa, I. García García, M. J. Linares, F. Marco, P. Merino, J. Pemán, L. Pérez del Molino, E. Roselló Mayans, C. Rubio Calvo, M. Ruiz Pérez de Pipaon, G. Yagüe, G. Garcia-Effron, J. Guinea, D. S. Perlin, M. Sanguinetti, R. Shields, and J. Turnidge. A multi-center study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin and micafungin using the Sensititre YeastOne colorimetric method. Antimicrob. Agents Chemother. 2015 Nov;59(11):6725-32.
  5. Govender NP, Roy M, Mendes JF, Zulu TG, Chiller TM and Karstaedt AS. Evaluation of Screening and Treatment of Cryptococcal Antigenaemia among HIV-infected Persons in Soweto, South Africa. HIV Med 2015. 2015 Sep;16(8):468-76.
  6. Smidt MC, Singh-Moodley A, Badat R, Quan V, Kularatne R, Nana T, Lekalakala R, Govender NP, Perovic O; for GERMS-SA. Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa. Int J Infect Dis. 2015 Jan; 30:41-8.
  7. Perovic O, Iyaloo S, Kularatne R, Lowman W, Bosman N, Wadula J, Seetharam S, Duse A, Mbelle N, Bamford C, Dawood H, Mahabeer Y, Bhola P, Abrahams S, Singh-Moodley A. Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology. PLOS One 2015;10(12):e0145429.
  8. de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. Nosocomial Outbreak of New Delhi Metallo-β-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study. PLOS One 2015;10(4):e0123337.
  9. Singh-Moodley A, Ekermans P and Perovic O. Emerging Carbapenem-Resistant Enterobacter cloacae Producing OXA-48-, VIM- and IMP-Type-β-lactamases in Eastern Cape Hospitals in South Africa. Open J Med Microbiol 2015; 5, 246-253.
  10. Singh-Moodley A, Marais E and Perovic O. Discrepancies between Genotypic and Phenotypic identification of Methicillin-Resistant Staphylococcus aureus and absence of mecC in surveillance isolates in South Africa. S Afr J Infect Dis 2015; 1(1):1-3.



  1. van Hougenhouck-Tulleken WG, Papavarnavas NS, Nel JS, Blackburn LY, Govender NP, Spencer DC, Lippincott CK. HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa. Emerg Infect Dis. 2014 Dec;20(12):2164-6.
  2. Govender NP and Dlamini S. Management of HIV-associated cryptococcal disease in South Africa. S Afr Med J 2014;104 (12): 896.
  3. Kenyon C, Corcoran C, Govender NP. An Emmonsia species causing disseminated infection in South Africa – authors’ reply. N Engl J Med. 2014 Jan 16;370(3):284.
  4. Loyse A, Thangaraj H, Govender NP, Harrison T, Bicanic T; all authors. Access to antifungal medicines in resource-poor countries – authors’ reply. Lancet Infect Dis. 2014 May;14(5):371.
  5. Magobo RE, Corcoran C, Seetharam S, Govender NP. Candida auris-Associated Candidemia, South Africa. Emerg Infect Dis. 2014 Jul;20(7):1250-1. doi: 10.3201/eid2007.
  6. Jarvis JN, Bicanic T, Loyse A, Meintjes G, Hogan L, Roberts CH, Shoham S, Perfect JR, Govender NP, Harrison TS. Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal Meningitis. Clin Infect Dis. 2014 Aug 15;59(4):493-500.
  7. Govender NP, Meintjes G and Banoo S. Access to flucytosine for HIV-infected patients with cryptococcal meningitis: an urgent need. S Afr Med J. 2014;104(9):594-595.
  8. Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W; Working Group from the EMBO-AIDS Related Mycoses Workshop, Achan B, Alber G, Aloisi M, Armstrong-James D, Beale M, Bicanic T, Black J, Bohjanen P, Botes A, Boulware DR, Brown G, Bunjun R, Carr W, Casadevall A, Chang C, Chivero E, Corcoran C, Cross A, Dawood H, Day J, De Bernardis F, De Jager V, De Repentigny L, Denning D, Eschke M, Finkelman M, Govender N, Gow N, Graham L, Gryschek R, Hammond-Aryee K, Harrison T, Heard N, Hill M, Hoving JC, Janoff E, Jarvis J, Kayuni S, King K, Kolls J, Kullberg BJ, Lalloo DG, Letang E, Levitz S, Limper A, Longley N, Machiridza TR, Mahabeer Y, Martinsons N, Meiring S, Meya D, Miller R, Molloy S, Morris L, Mukaremera L, Musubire AK, Muzoora C, Nair A, Nakiwala Kimbowa J, Netea M, Nielsen K, O’hern J, Okurut S, Parker A, Patterson T, Pennap G, Perfect J, Prinsloo C, Rhein J, Rolfes MA, Samuel C, Schutz C, Scriven J, Sebolai OM, Sojane K, Sriruttan C, Stead D, Steyn A, Thawer NK, Thienemann F, Von Hohenberg M, Vreulink JM, Wessels J, Wood K, Yang YL. AIDS-related mycoses: the way forward. Trends Microbiol. 2014 Mar;22(3):107-9.
  9. van Wyk M, Govender NP, Mitchell TG, Litvintseva AP; GERMS-SA. Multilocus Sequence Typing of Serially Collected Isolates of Cryptococcus from HIV-Infected Patients in South Africa. J Clin Microbiol. 2014 Jun;52(6):1921-31.
  10. Lochan H, Naicker P, Maphanga T, Ryan A, Pillay K, Govender NP, Eley B. A case of emmonsiosis in an HIV-infected child. S Afr J HIV Med 2014; 16(1): e1-e4
  11. Govender NP, Magobo RE, Zulu TG, du Plooy M and Corcoran C. Disseminated fatal Talaromyces (Pencillium) marneffei infection in a returning HIV-infected traveller. S Afr J HIV Med 2014; 15(4): e1-e2
  12. Perovic O, Singh-Moodley A, Dusé A, Bamford C, Elliott G, Swe-Han KS, Kularatne R, Lowman W, Whitelaw A, Nana T, Wadula J, Lekalakala R, Saif A, Fortuin De-Smit M, Marais E. National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010 – 2012. S Afr Med J 2014 Jun 19;104(8):563-8.



  1. Kenyon C, Bonorchis K, Corcoran C, Meintjes G, Locketz M, Lehloenya R, Vismer HF, Naicker P, Prozesky H, van Wyk M, Bamford C, du Plooy M, Imrie G, Dlamini S, Borman AM, Colebunders R, Yansouni CP, Mendelson M and Govender NP. A Dimorphic Fungus Causing Disseminated Infection in South Africa. N Engl J Med. 2013; 369:1416-24.
  2. Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, Govender N, Harrison TS, Bicanic T. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013 Jul;13(7):629-37. doi: 10.1016/S1473-3099(13)70078-1.
  3. Govender NP, Meintjes G, Bicanic T, Dawood H, Harrison TS, Jarvis JN, Karstaedt AS, Maartens G, McCarthy KM, Rabie H, Variava E and Venter WDF (SA HIV Clinicians’ Society). Guideline for Prevention, Diagnosis and Management of Cryptococcal Meningitis among HIV-infected Persons: 2013 Update. S Afr J HIV Med 2013;14(2):76-86.
  4. Lewis DA, Gumede LY, van der Hoven LA, de Gita GN, de Kock EJ, de Lange T, Maseko V, Kekana V, Smuts FP, Perovic O. Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province, South Africa. S Afr Med J 2013;103(6):377-81.



  1. Klausner J, Govender N, Oladoyinbo S, Roy M, Chiller T. Response to Parkes-Ratanshi R, Wakeham K, Levin J, et al. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomized, placebo-controlled trial. Lancet Infect Dis. 2012 Jun;12(6):431-2.
  2. Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, McCarthy KM, Whitelaw AC, Govender NP; for the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA). A comparison of paediatric- and adult-onset cryptococcosis detected through population-based surveillance in South Africa, 2005-2007. AIDS. 2012 Nov 28;26(18):2307-14.
  3. Jarvis JN, Govender N, Chiller T, Park BJ, Longley N, Meintjes G, Bekker LG, Wood R, Lawn SD, Harrison TS. Cryptococcal Antigen Screening and Pre-emptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings: A Proposed Algorithm for Clinical Implementation. J Int Assoc Physicians AIDS Care 2012 Nov-Dec;11(6):374-9.
  4. Govender NP, Roy M, Oladoyinbo S, Maotoe T, Stevens W, Pinini Z, Spencer D, Venter WDF, Jassat W, Cameron D, Meintjes G, Chiller T, Chetty V, Mbengashe T and Pillay Y for the South African Cryptococcal Screening Initiative Group. Phased Implementation of Screening for Cryptococcal Disease in South Africa. S Afr Med J. 2012 Oct 8;102(12):914-7.
  5. Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J. Cryptococcus neoformans-Cryptococcus gattii Species Complex: An International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole and Voriconazole. Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906.
  6. Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, Fothergill A, Fuller J, Hagen F, Govender N, Guarro J, Johnson E, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, Trilles L, Kidd S, Turnidge J. Cryptococcus neoformans-Cryptococcus gattii Species Complex: An International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine. Antimicrob Agents Chemother. 2012 Jun;56(6):3107-13.
  7. Frean J, Perovic O, Fensham V, McCarthy K, von Gottberg A, de Gouveia L, Poonsamy B, Dini L, Rossouw J, Keddy K, Alemu W, Yahaya A, Pierson A, Dolmazon V, Cognat S, Ndihokubwayo JB. External quality assessment of national public health laboratories in Africa, 2002-2009. Bull World Health Org 2012;90(3):191-199A.



  1. Rossouw I, Goedhals D, van der Merwe J, Stallenberg V, Govender N. A rare, fatal case of invasive spinal aspergillosis in an antiretroviral-naive, HIV-infected man with pre-existing lung colonization. J Med Microbiol. 2011 Oct;60(Pt 10):1534-8.
  2. Litvintseva AP, Carbone I, Rossouw J, Thakur R, Govender NP, Mitchell TG. Evidence that the human pathogenic fungus Cryptococcus neoformans grubii may have evolved in Africa. PLoS One. 2011 May 11;6(5):e19688.
  3. Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, Maartens G, Venter F, Bekker LG, Wood R, Meintjes G. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts–time to implement in South Africa? S Afr Med J. 2011 Apr;101(4):232-4.
  4. Park BJ, Shetty S, Ahlquist A, Greenbaum A, Miller JL, Motsi A, McCarthy K, Govender N; for the Gauteng Cryptococcal Surveillance Initiative Group. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa. Int J STD AIDS. 2011 Apr;22(4):199-203
  5. Govender NP, Patel J, van Wyk M, Chiller TM, Lockhart SR; for the Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA). Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Obtained Through Population-based Surveillance, South Africa, 2002-2003 and 2007-2008. Antimicrob Agents Chemother. 2011 Jun;55(6):2606-11.
  6. Miglia KJ, Govender NP, Rossouw J, Meiring S, Mitchell TG; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Analyses of pediatric isolates of Cryptococcus neoformans from South Africa. J Clin Microbiol. 2011 Jan;49(1):307-14.
  7. Govender NP, Chiller T, Poonsamy B and Frean JA. Neglected Fungal Diseases in sub-Saharan Africa: A Call to Action. Curr Fungal Infect Rep. 2011; 5:224-32.
  8. Mackay CA, Ballot DE, Perovic O. Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates. Pediatric Rep 2011 Jun 16;3(2):e14.



  1. Cohen C, Singh E, Wu HM, Martin S, de Gouveia L, Klugman KP, Meiring S, Govender N, von Gottberg A; Group for Enteric, Respiratory and Meningeal disease Surveillance in South Africa (GERMS-SA). Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa. AIDS. 2010 Jun 1;24(9):1351-60.



  1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009 Feb 20;23(4):525-30.



  1. von Gottberg A, Klugman KP, Cohen C, Wolter N, de Gouveia L, du Plessis M, Mpembe R, Quan V, Whitelaw A, Hoffmann R, Govender N, Meiring S, Smith AM, Schrag S; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet. 2008 Mar 29;371(9618):1108-13.



  1. McCarthy KM, Meintjes G, Arthington-Skaggs B, Bicanic T, Cotton M, Chiller T, Govender N, Harrison T, Karstaedt AS, Maartens G, Rabie H, Varavia E, Venter WDF, Vismer H (SA HIV Clinicians’ Society). Guidelines for the Prevention, Diagnosis and Management of Cryptococcal Meningitis and Disseminated Cryptococcosis in HIV-infected patients. S Afr J HIV Med 2007;Spring edition:25-35.